Zimmer Biomet Holdings, Inc. (ZBH) Q2 2017 Earnings Results

Zimmer Biomet Misses on EPS — Stock Down 2.53%

Zimmer Biomet's earnings report shows a slight miss on EPS, which contributed to a 2.53% decline in stock price. The company is facing challenges in the market, and management's cautious tone suggests that investors should be prepared for potential headwinds ahead. Without updated guidance, uncertainty remains about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.08	N/A	-1.33%

Management

Management commentary

Tone: Defensive

Management expressed concerns about market conditions affecting performance. They emphasized their commitment to improving operational efficiency.

We are navigating a challenging market environment.

Our focus remains on operational efficiency and innovation.

Zimmer Biomet Misses on EPS — Stock Down 2.53%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Misses on EPS — Stock Down 2.53%

Key numbers

Management commentary